SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-08-006665
Filing Date
2008-10-24
Accepted
2008-10-24 12:34:18
Documents
7
Period of Report
2008-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b72696oxe8vk.htm 8-K 27938
2 EX-10.1 FORM OF INDEMNIFICATION AGREEMENT BETWEEN OXIGENE AND ITS DIRECTORS b72696oxexv10w1.htm EX-10.1 16391
3 EX-10.2 OXIGENE, INC. AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY b72696oxexv10w2.htm EX-10.2 12577
4 EX-10.3 SEPARATION AGREEMENT BETWEEN OXIGENE AND DR. CHIN DATED OCTOBER 22, 2008 b72696oxexv10w3.htm EX-10.3 22938
5 EX-10.4 AMENDMENT NO. 3 EMPLOYMENT AGREEMENT, DATED OCTOBER 22, 2008 b72696oxexv10w4.htm EX-10.4 8082
6 EX-99.1 PRESS RELEASE DATED OCTOBER 23, 2008 b72696oxexv99w1.htm EX-99.1 9502
7 GRAPHIC b72696oxb7269601.gif GRAPHIC 5695
  Complete submission text file 0000950135-08-006665.txt   106958
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 081139152
SIC: 2836 Biological Products, (No Diagnostic Substances)